Japan’s Finance Minister Kato flags impact of rising rates, pledges stable bond issuanceMarch 11, 2025
Market Trends Beam drops 9% on phase 1/2 data for genetic lung disease candidateBy admin8996erT0allMarch 10, 2025 Hiroshi Watanabe Beam Therapeutics (NASDAQ:BEAM) is down ~9% in Monday afternoon trading after reporting initial phase 1/2 data on BEAM-302…
Market Trends 23andMe CEO Wojcicki, New Mountain offer to purchase genetic testing company (ME:NASDAQ)By admin8996erT0allFebruary 21, 2025 JasonDoiy23andMe (NASDAQ:ME) co-founder and CEO Anne Wojcicki and private equity firm New Mountain Capital offered to purchase the genetic testing…
